Lawes CMM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part 1: estimates of blood pressure levels. J Hypertens. 2006;24:413–22.

Article  CAS  PubMed  Google Scholar 

Mills KT, Bundy JD, Kelly TN, Reed J, Kearney PM, Reynolds K, et al. Abstract 16828: global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2015;132.

Cavalcante JL, Lima JAC, Redheuil A, Al-Mallah MH. Aortic stiffness. J Am Coll Cardiol. 2011;57:1511–22.

Article  PubMed  Google Scholar 

Bluemke DA, Kronmal RA, Lima JAC, Liu K, Olson J, Burke GL, et al. The relationship of left ventricular mass and geometry to incident cardiovascular events. J Am Coll Cardiol. 2008;52:2148–55.

Article  PubMed  PubMed Central  Google Scholar 

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Eur Heart J. 2013;34:2159–219.

Article  PubMed  Google Scholar 

Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension. 2004;43:731.

Article  CAS  PubMed  Google Scholar 

Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005;111:3384–90.

Article  PubMed  Google Scholar 

Redheuil A, Wu CO, Kachenoura N, Ohyama Y, Yan RT, Bertoni AG, et al. Proximal aortic distensibility is an independent predictor of all-cause mortality and incident CV events: the MESA study. J Am Coll Cardiol. 2014;64:24.

Article  Google Scholar 

Tsao CW, Gona PN, Salton CJ, Chuang ML, Levy D, Manning WJ, et al. Left ventricular structure and risk of cardiovascular events: a framingham heart study cardiac magnetic resonance study. J Am Heart Assoc. 2015;4:9.

Article  Google Scholar 

Mitchell GF, Hwang S-J, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, et al. Arterial stiffness and cardiovascular events. Circulation. 2010;121:505–11.

Article  PubMed  PubMed Central  Google Scholar 

Franklin SS, Wong ND. Hypertension and cardiovascular disease: contributions of the Framingham Heart Study. Glob Heart. 2013;8:59.

Article  Google Scholar 

Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, et al. Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2014;37:599–599.

Article  CAS  Google Scholar 

Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.

Article  PubMed  Google Scholar 

Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamuchi M, et al. Current status fo antihypertensive prescription and associated blood pressure control in Japan. Hypertens Res. 2006;29:143.

Article  CAS  PubMed  Google Scholar 

Habboush S, Sofy AA, Masoud AT, Cherfaoui O, Farhat AM, Abdelsattar AT, et al. Efficacy of single-pill, triple antihypertensive therapy in patients with uncontrolled hypertension: a systematic review and meta-analysis. High Blood Press Cardiovasc Prev [Internet]. 2022;29:245–52. https://doi.org/10.1007/s40292-022-00511-y.

Article  CAS  PubMed  Google Scholar 

Mostafa S, Shabana H, Khalil F, Mancy IM, Zedan HAM, Elmoursi A, et al. Evaluation of the safety and efficacy of dual therapy perindopril/amlodipine in the management of hypertension a systematic review and meta-analysis. High Blood Press Cardiovasc Prev [Internet]. 2022;29:565–76. https://doi.org/10.1007/s40292-022-00544-3.

Article  CAS  PubMed  Google Scholar 

Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med. 2003;115:41.

Article  PubMed  Google Scholar 

Sofy AA, Abdelsattar AT, Mohammed OM, Shareef MA, Alamodi AA, Nso N, et al. Amlodipine compared with benidipine in the management of hypertension: a systematic review and meta-analysis. High Blood Press Cardiovasc Prev. 2020;27:527.

Article  CAS  PubMed  Google Scholar 

Schiffrin EL. Circulatory therapeutics: Use of antihypertensive agents and their effects on the vasculature. J Cell Mol Med. 2010;14:1018–29.

CAS  PubMed  PubMed Central  Google Scholar 

Heeneman S, Sluimer JC, Daemen MJAP. Angiotensin-converting enzyme and vascular remodeling. Circ Res. 2007;101:441.

Article  CAS  PubMed  Google Scholar 

Ponikowski P, Voors AA, Anker DS, Bueno H, Cleland GFJ, Coats JSA, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Russ J Cardiol. 2017;7–81

Verdecchia P, Sleight P, Mancia G, Fagard R, Trimarco B, Schmieder RE, et al. Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the ongoing telmisartan alone and in combination with ramipril global end point trial and the telmisartan randomized assessment. Circulation. 2009;120:1380–9.

Article  CAS  PubMed  Google Scholar 

Zannad F, Fay R. Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randomized controlled studies. Fundam Clin Pharmacol. 2007;21:181.

Article  CAS  PubMed  Google Scholar 

Nakajima T, Oh A, Saita S, Yoshida T, Ohishi M, Nishigaki N. Comparative effectiveness of angiotensin II receptor blockers in patients with hypertension in Japan—systematic review and network meta-analysis. Circ Rep. 2020;2:576.

Article  PubMed  PubMed Central  Google Scholar 

Tsoi B, Akioyamen LE, Bonner A, Frankfurter C, Levine M, Pullenayegum E, et al. Comparative efficacy of angiotensin ii antagonists in essential hypertension: systematic review and network meta-analysis of randomised controlled trials. Hear Lung Circ. 2018;27:666.

Article  Google Scholar 

Segura J, Ruilope LM. Dual-acting angiotensin receptor-neprilysin inhibition. Curr Hypertens Rep. 2011;13:74–8.

Article  CAS  PubMed  Google Scholar 

Cheung DG, Aizenberg D, Gorbunov V, Hafeez K, Chen C-W, Zhang J. Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: a randomized, double-blind, 8-week study. J Clin Hypertens. 2018;20:150–8.

Article  CAS  Google Scholar 

Supasyndh O, Wang J, Hafeez K, Zhang Y, Zhang J, Rakugi H. Efficacy and safety of sacubitril/valsartan (LCZ696) compared with olmesartan in elderly asian patients (≥65 years) with systolic hypertension. Am J Hypertens. 2017;30:1163–9.

Article  CAS  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021.

Higgins JPT, S G. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated]. Cochrane Database Syst Rev. 2011.

De Vecchis R, Ariano C, Soreca S. Antihypertensive effect of sacubitril/valsartan: a meta-analysis. Minerva Cardioangiol. 2019;67:3.

Article  Google Scholar 

Nixon RM, Müller E, Lowy A, Falvey H. Valsartan vs other angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approach. Int J Clin Pract. 2009;63:766–75.

Article  CAS  PubMed  Google Scholar 

Wang L, Zhao JW, Liu B, Shi D, Zou Z, Shi XY. Antihypertensive effects of olmesartan compared with other angiotensin receptor blockers: a meta-analysis. Am J Cardiovasc Drugs. 2012;12:335.

Article  CAS  PubMed  Google Scholar 

Cappuccio FP, Miller MA. Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions. Intern Emerg Med. 2016;11:299.

Article  PubMed  PubMed Central  Google Scholar 

Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003;290:486.

Article  CAS  PubMed  Google Scholar 

Smith DHG, Dubiel R, Jones M. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy. Am J Cardiovasc Drugs. 2005;5:41–50.

Article  CAS  PubMed  Google Scholar 

Baguet JP, Robitail S, Boyer L, Debensason D, Auquier P. A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. Am J Cardiovasc Drugs. 2005;5:131.

Article  CAS  PubMed  Google Scholar 

Gallo G, Tocci G, Fogacci F, Battistoni A, Rubattu S, Volpe M. Blockade of the neurohormonal systems in heart failure with preserved ejection fraction: a contemporary meta-analysis. Int J Cardiol. 2020;316:172.

Article  PubMed  Google Scholar 

Rakugi H, Kario K, Yamaguchi M, Sasajima T, Gotou H, Zhang J. Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study. Hypertens Res. 2022;45:824–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Supasyndh O, Sun N, Kario K, Hafeez K, Zhang J. Long-term (52-week) safety and efficacy of Sacubitril/valsartan in Asian patients with hypertension. Hypertens Res. 2017;40:472.

Article  CAS  PubMed  Google Scholar 

Kario K, Sun N, Chiang FT, Supasyndh O, Baek SH, Inubushi-Molessa A, et al. Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in asian patients with hypertension: a randomized, double-blind, placebo-controlled study. Hypertension. 2014;63:698.